Mesalamine-induced pneumonitis during therapy for chronic inflammatory bowel disease: A pediatric case report

Journal of Pediatric Gastroenterology and Nutrition

Volumn 41, Issue 4, 2005, Pages 479-482

  Kohli, Rohit ^a   Melin Aldana, Hector ^a   Sentongo, Timothy A ^a,b  

^a NORTHWESTERN UNIVERSITY   (United States)

^b CHILDREN'S MEMORIAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; FERROUS SULFATE; FOLIC ACID; MESALAZINE; PREDNISONE; SALBUTAMOL; STEROID; SULFALAZINE;

ARTICLE; ASTHMA; CASE REPORT; CLINICAL FEATURE; COLONOSCOPY; COMPUTER ASSISTED TOMOGRAPHY; COUGHING; DIAGNOSTIC IMAGING; DIARRHEA; DIFFERENTIAL DIAGNOSIS; ENTERITIS; ERYTHROCYTE CONCENTRATE; ERYTHROCYTE TRANSFUSION; FATIGUE; FEMALE; FEVER; FOLLOW UP; HEMATOCHEZIA; HISTOLOGY; HUMAN; IMAGE ANALYSIS; INTESTINE BIOPSY; LETHARGY; MICROCYTIC ANEMIA; OPEN LUNG BIOPSY; PNEUMONIA; PRIORITY JOURNAL; SCHOOL CHILD; SYMPTOM; THORAX PAIN;

ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; CHILD; DIAGNOSIS, DIFFERENTIAL; FEMALE; HUMANS; INFLAMMATORY BOWEL DISEASES; MESALAMINE; PNEUMONIA; TOMOGRAPHY, X-RAY COMPUTED;

EID: 26044439020     PISSN: 02772116     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.mpg.0000173601.31647.84     Document Type: Article

References (23)

1. Bernstein CN, Kolodny M, Block E, et al. Pneumocystis carinii pneumonia in patients with ulcerative colitis treated with corticosteroids. Am J Gastroenterol 1993;88:574-7.
2. van Wijngaarden P, Meijssen MA. Tuberculous pleurisy: an unusual complication during treatment of Crohn disease with azathioprine. Scand J Gastroenterol 2001;36:1004-7.
3. Calder CJ, Lacy D, Raafat F, et al. Crohn's disease with pulmonary involvement in a 3 year old boy. Gut 1993;34:1636-8.
4. Bentur L, Lachter J, Koren I, et al. Severe pulmonary disease in association with Crohn's disease in a 13-year-old girl. Pediatr Pulmonol 2000;29:151-4.
5. Puntis JW, Tarlow MJ, Raafat F, et al. Crohn's disease of the lung. Arch Dis Child 1990;65:1270-1.
6. Foster RA, Zander DS, Mergo PJ, et al. Mesalamine-related lung disease: clinical, radiographic, and pathologic manifestations. Inflamm Bowel Dis 2003;9:308-15.
7. Scott AM, Myers GA, Harms BA. Pneumocystis carinii pneumonia postrestorative proctocolectomy for ulcerative colitis: a role for perioperative prophylaxis in the cyclosporine era? Report of a case and review of the literature. Dis Colon Rectum 1997;40:973-6.
8. Hanauer SB, Sninsky CA, Robinson M. An oral preparation of mesalamine as long-term maintenance therapy for ulcerative colitis. A randomized, placebo-controlled trial. The Mesalamine Study Group. Ann Intern Med 1996;124:204-11.
9. Sentongo TA, Piccoli DA. Recurrent pericarditis due to mesalamine hypersensitivity: a pediatric case report and review of the literature. J Pediatr Gastroenterol Nutr 1998;27:344-7.
10. Zinck SE, Schwartz E, Berry GJ, et al. CT of noninfectious granulomatous lung disease. Radiol Clin North Am 2001;39:1189-20.
11. Casey MB, Tazelaar HD, Myers JL, et al. Noninfectious lung pathology in patients with Crohn's disease. Am J Surg Pathol 2003; 27:213-9.
12. Yi ES. Hypersensitivity pneumonitis. Crit Rev Clin Lab Sci 2002; 39:581-629.
13. Glazer CS, Rose CS, Lynch DA. Clinical and radiologic manifestations of hypersensitivity pneumonitis. J Thorac Imaging 2002;17: 261-72.
14. Sossai P, Cappellato MG, Stefani S. Can a drug-induced pulmonary hypersensitivity reaction be dose-dependent? A case with mesalamine. Mt Sinai J Med 2001;68:389-95.
15. Sesin GP, Mucciardi N, Almeida S. Mesalamine-associated pleural effusion with pulmonary infiltration. Am J Health Syst Pharm 1998; 55:2304-5.
16. Cheung OY, Muhm JR, Helmers RA, et al. Surgical pathology of granulomatous interstitial pneumonia. Ann Diagn Pathol 2003;7: 127-38.
17. le Gros V, Saveuse H, Lesur G, et al. Lung and skin hypersensitivity to 5-aminosalicylic acid. BMJ 1991;302:970.
18. Sviri S, Gafanovich I, Kramer MR, et al. Mesalamine-induced hypersensitivity pneumonitis. A case report and review of the literature. J Clin Gastroenterol 1997;24:34-6.
19. Campieri M, Lanfranchi GA, Boschi S, et al. Topical administration of 5-aminosalicylic acid enemas in patients with ulcerative colitis. Studies on rectal absorption and excretion. Gut 1985;26:400-5.
20. Bitton A, Peppercorn MA, Hanrahan JP, et al. Mesalamine-induced lung toxicity. Am J Gastroenterol 1996;91:1039-40.
21. Gonzalo MA, Alcalde MM, Garcia JM, et al. Desensitization after fever induced by mesalazine. Allergy 1999;54:1224-5.
22. Anon. Measuring childhood asthma prevalence before and after the 1997 redesign of the National Health Interview Survey: United States. MMWR Morb Mortal Wkly Rep 2000;49:908-11.
23. Colombel JF, Loftus EV, Jr., Tremaine WJ, et al. The safety profile of infliximab in patients with Crohn's disease: the Mayo clinic experience in 500 patients. Gastroenterology 2004;126: 19-31.